The sustained insider selling by a former officer, including this new 144 filing, is a bearish signal. Traders should monitor for any negative news or upcoming earnings that might prompt further insider exits. The stock's recent volatility (historical reports show significant drawdowns) suggests caution.
Price Chart
Executive Summary
Richard B. Bartram, a former officer of MBX Biosciences, filed a Form 144 on May 11, 2026, indicating intent to sell 22,500 shares of common stock with an approximate market value of $991,901. The shares are sourced from the exercise of stock options granted between 2022 and 2025. This filing follows a series of recent insider sales by Bartram totaling over $1.5 million in the past two months, signaling potential insider profit-taking ahead of any upcoming catalysts.
Key Facts
- Former officer Richard B. Bartram filed Form 144 to sell 22,500 shares valued at ~$991,901.
- Shares are from exercised stock options granted on 04/20/2022, 11/07/2022, 08/15/2023, and 02/03/2025.
- Bartram has sold ~46,484 shares for ~$1.53 million in the 60 days prior to this filing (March 16 – May 8, 2026).
- The filing was made on May 11, 2026, with the sale to occur on the same day on NASDAQ.
- MBX has a market cap of $1.9B; the proposed sale represents ~0.05% of shares outstanding.
Financial Impact
Proposed sale of $991,901 in stock by a former officer, part of a recent insider selling pattern totaling ~$1.53 million over two months.
Risk Factors
- Insider selling may indicate lack of confidence in near-term prospects or upcoming negative catalysts.
- The proposed sale may not be completed, but the pattern of recent sales is concerning.
- MBX is a pre-revenue biotech; any pipeline setbacks could amplify downside.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-003490 |
| Document: 0001959173-26-003490-index.html | 0001959173-26-003490 |
| Document: 0001959173-26-003490.txt | 0001959173-26-003490 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 3 | $50.46 $48.50 | ▼ −3.88% | ▼ −3.36% | $50.29 (−0.34%) |
Oct 22, 2026 4d ago | 8-K | $50.46 $48.50 | ▼ −3.88% | ▼ −3.36% | $50.29 (−0.34%) |
Aug 27, 2026 8w ago | Press Release | $66.39 $63.00 | ▼ −5.11% | ▼ −4.88% | $50.29 (−24.25%) |
Aug 17, 2026 10w ago | 144 | $68.25 $66.52 | ▼ −2.53% | ▼ −1.86% | $50.29 (−26.32%) |
Aug 6, 2026 11w ago | 8-K | $67.11 $67.82 | ▲ +1.06% | ▲ +0.45% | $50.29 (−25.06%) |
Jun 12, 2026 19w ago | 8-K | $35.51 $38.98 | ▲ +9.77% | ▲ +8.01% | $50.29 (+41.62%) |
Jun 12, 2026 19w ago | Press Release | $35.51 $38.98 | ▲ +9.77% | ▲ +8.01% | $50.29 (+41.62%) |
Jun 11, 2026 19w ago | Institutional Cluster | $37.25 $35.51 | ▼ −4.67% | ▼ −5.21% | $50.29 (+35.01%) |
Jun 11, 2026 19w ago | Institutional Cluster | $37.25 $35.51 | ▼ −4.67% | ▼ −5.21% | $50.29 (+35.01%) |
Jun 10, 2026 19w ago | 144 | $30.99 $37.25 | ▲ +20.20% | ▲ +18.50% | $50.29 (+62.28%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers